Andreas Halvorsen’s 10x Genomics TXG Stock Holding History

Andreas Halvorsen’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-71,069	Closed	-$3.58M	–	77
2019 Q3	$3.58M	Buy	+71,069	New	+$3.93M	0.02%	61

Other funds holding TXG

FCMI

Foresite Capital Management I Larkspur, California $21.4M AUM 80.48% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

JCM

JS Capital Management New York $223M AUM 104.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Andreas Halvorsen's TXG Position: Q4 2019 in Review

Andreas Halvorsen sold out of 10x Genomics (TXG) in Q4 2019, closing a stake of 71,069 shares — an estimated $3.58M sold.

Andreas Halvorsen first reported a position in TXG in Q3 2019 and held it in 1 quarter. The position peaked at $3.58M in Q3 2019. 85 funds tracked by Wall St. Rank hold TXG as of Q4 2019.

Andreas Halvorsen reported no remaining 10x Genomics position as of Q4 2019 after selling out during the quarter.
Andreas Halvorsen sold 71,069 10x Genomics shares in Q4 2019, an estimated $3.58M.
Andreas Halvorsen first reported a position in 10x Genomics in Q3 2019 and held it in 1 quarter.
Andreas Halvorsen's 10x Genomics position peaked at $3.58M in Q3 2019.
85 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2019.

Based on Viking Global Investors's 13F filing for Q4 2019, filed 13 Feb 2020.